{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:10:37Z","timestamp":1788909037213,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bmc.2020.115826","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T22:25:20Z","timestamp":1603837520000},"page":"115826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay"],"prefix":"10.1016","volume":"28","author":[{"given":"Takeru","family":"Furuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Comita-Prevoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Kuenstner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth D.","family":"Ribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir H.","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.C.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo V.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Durand-Reville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alita A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben A.","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115826_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2020.115826_b0010","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1073\/pnas.0705833104","article-title":"Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase","volume":"104","author":"Williams","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2020.115826_b0015","doi-asserted-by":"crossref","first-page":"a025304","DOI":"10.1101\/cshperspect.a025304","article-title":"Antibacterial drug discovery targeting the lipopolysaccharide biosynthetic enzyme LpxC","volume":"6","author":"Erwin","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bmc.2020.115826_b0020","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.275.15.11002","article-title":"Antibacterial agents that target lipid A biosynthesis in gram-negative bacteria. Inhibition of diverse UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylases by substrate analogs containing zinc binding motifs","volume":"275","author":"Jackman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2020.115826_b0025","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/AAC.46.6.1793-1799.2002","article-title":"Antibacterial activities and characterization of novel inhibitors of LpxC","volume":"46","author":"Clements","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115826_b0030","doi-asserted-by":"crossref","first-page":"16574","DOI":"10.1021\/bi0518186","article-title":"A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid a biosynthesis with antibiotic activity comparable to ciprofloxacin \u2020","volume":"44","author":"McClerren","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2020.115826_b0035","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/jm2014875","article-title":"Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections","volume":"55","author":"Montgomery","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115826_b0040","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/jm2014748","article-title":"Potent inhibitors of LpxC for the treatment of gram-negative infections","volume":"55","author":"Brown","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115826_b0045","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1021\/acs.jmedchem.7b00377","article-title":"Design, synthesis, and properties of a potent inhibitor of Pseudomonas aeruginosa deacetylase LpxC","volume":"60","author":"Piizzi","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115826_b0050","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.bmcl.2017.03.006","article-title":"Structure-based discovery of LpxC inhibitors","volume":"27","author":"Zhang","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115826_b0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/acs.jmedchem.9b01604","article-title":"Discovery of novel inhibitors of LpxC displaying potent in Vitro activity against gram-negative bacteria","volume":"63","author":"Surivet","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115826_b0060","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.274.5289.980","article-title":"Antibacterial agents that inhibit lipid A biosynthesis","volume":"274","author":"Onishi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bmc.2020.115826_b0065","unstructured":"US SEC, Form S-1, Achaogen, Inc. www.sec.gov\/Archives\/edgar\/data\/1301501\/000119312514020548\/d623715ds1.htm [accessed 18 September 2020]."},{"key":"10.1016\/j.bmc.2020.115826_b0070","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03832517 [accessed 18 September 2020]."},{"key":"10.1016\/j.bmc.2020.115826_b0075","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/cmdc.201900287","article-title":"Optimization of LpxC inhibitors for antibacterial activity and cardiovascular safety","volume":"14","author":"Cohen","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2020.115826_b0080","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1124\/dmd.108.022566","volume":"36","author":"Dalvie","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmc.2020.115826_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67112-4","article-title":"Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines","volume":"10","author":"Sixto-L\u00f3pez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2020.115826_b0090","first-page":"4300","article-title":"Metabolic activation of the potent mutagen, 2-naphthohydroxamic acid, in Salmonella typhimurium TA98","volume":"50","author":"Lee","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2020.115826_b0095","unstructured":"R\u00e9v\u00e9sz L, Schlapbach A, W\u00e4lchl R. Pyrrolo isoquinolines as kinase inhibitors. WO2008025512A1; 2008."},{"key":"10.1016\/j.bmc.2020.115826_b0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1039\/p19960000883","article-title":"Synthesis of 1-acylamino-1-(trimethylsiloxy)alkanes by trimethylsilyl trifluoromethanesulfonate-catalysed addition of bis(trimethylsilyl)amides to aldehydes","volume":"1","author":"Johnson","year":"1996","journal-title":"J Chem Soc, Perkin Trans"},{"key":"10.1016\/j.bmc.2020.115826_b0105","doi-asserted-by":"crossref","unstructured":"Johnson AP, Luke RWA, Boa AN. Reactions of 1-acylamino-1-(trimethylsi1oxy)alkanes: versatile precursors to acylimines. J Chem Soc - Perkin Trans 1. 1996;(9):895\u2013905. https:\/\/doi.org\/10.1039\/p19960000895.","DOI":"10.1039\/p19960000895"},{"key":"10.1016\/j.bmc.2020.115826_b0110","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bmcl.2010.12.111","article-title":"Design and synthesis of potent Gram-negative specific LpxC inhibitors","volume":"21","author":"Mansoora","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115826_b0115","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1021\/jm0208875","article-title":"Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers","volume":"45","author":"Cavalli","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115826_b0120","unstructured":"Finch H, Van Niel BM, Woo C. Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract. WO2013083206A1; 2013."},{"key":"10.1016\/j.bmc.2020.115826_b0125","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1002\/anie.201504757","article-title":"RhIII-catalyzed C\u2212H activation with pyridotriazoles: direct access to fluorophores for metal-ion detection","volume":"54","author":"Kim","year":"2015","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2020.115826_b0130","unstructured":"Anderson NH, Bowman J, Erwin A, et al. Antibacterial agents. WO2004062601A2; 2004."},{"key":"10.1016\/j.bmc.2020.115826_b0135","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.bmcl.2013.02.055","article-title":"Exploring the UDP pocket of LpxC through amino acid analogs","volume":"23","author":"Hale","year":"2013","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115826_b0140","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/1087057106286653","article-title":"Correction for interference by test samples in high-throughput assays","volume":"14","author":"Shapiro","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bmc.2020.115826_b0145","unstructured":"Weinstein MP, Limbago B, Patel JB, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Wayne, PA, USA: Clinical and Laboratory Standards Institute. Document M07-A11; 2018."},{"key":"10.1016\/j.bmc.2020.115826_b0150","first-page":"859","article-title":"HKL-3000: the integration of data reduction and structure solution\u2013from diffraction images to an initial model in minutes","volume":"D62","author":"Minor","year":"2006","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bmc.2020.115826_b0155","first-page":"355","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"D67","author":"Murshudov","year":"2011","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bmc.2020.115826_b0160","first-page":"2126","article-title":"Coot: model-building tools for molecular graphics","volume":"D60","author":"Emsley","year":"2004","journal-title":"Acta Cryst"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620306568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620306568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:10:44Z","timestamp":1760836244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620306568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0968089620306568"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115826","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115826"}}